Las vesículas extracelulares podrían ser la clave para desarrollar terapias más seguras y efectivas en la enfermedad inflamatoria intestinal

by Institut d'Investigació Sanitària Pere Virgili (IISPV)

Investigadores del Instituto de Investigación Sanitària Pere Virgili (IISPV) y del Instituto de Investigación Germans Trias i Pujol (IGTP) han llevado a cabo una revisión sobre el potencial terapÃ...

Read more

Picks of November: medtech firm Impress closes second-ever megaround, important advances in tumors with CAR-T cells and new science facilities

by Biocat

Let’s look at the most noteworthy news from November, showcasing the vibrancy and constant innovation in the BioRegion of Catalonia, from basic research to clinical applications and international bu...

Read more

VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities

by VIVEbiotech

VIVEbiotech provides process development, manufacturing and analytical testing for leading biopharmaceutical companies engaged in gene therapy and cell therapy projects. With a specific focus on lenti...

Read more

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production

by Thermo Fisher Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibcoâ„¢ CTSâ„¢ Detachable Dynabeadsâ„¢ CD4 and CTS Detachable Dynabeads CD8 (CTS Detachable Dynabeads)

Read more

Part of the Solution: How Purification Experts Make Novel Drugs Safe for Use

by Sartorius Stedim Spain

A group of purification specialists in a small town in western Slovenia develops innovative technologies that separate right from wrong fast and efficiently – making sure patients worldwide receive ...

Read more

VHIO participates in the European COMBAT-PDAC project to improve the diagnosis and treatment of pancreatic cancer

by VHIO

The COMBAT-PDAC project aims to address this gap by focusing on understanding and targeting the whole spectrum of heterogeneous pancreatic cancer cells present in individual tumors

Read more

Investigadores españoles identifican el papel de unas proteínas que podrían prevenir efectos secundarios de las terapias CAR-T

by CIMA - Centro de Investigación Médica Aplicada

Un artículo publicado por especialistas del Cancer Center Clínica Universidad de Navarra en la revista Blood Advances presenta mecanismos moleculares que promueven la citopenia a largo plazo en paci...

Read more

Una investigación del IBiS desarrolla una nueva terapia CAR-T más efectiva para el tratamiento del mieloma múltiple

by Instituto de Biomedicina de Sevilla - IBIS

Este estudio del IBiS se centra en desarrollar una nueva versión mejorada de la terapia con células CAR-T, llamada CARTemis-1, diseñada específicamente para atacar de manera más eficiente una pro...

Read more

Especialistas en cáncer de hígado destacan 'el impacto transformador' de la inmunoterapia en tumores avanzados

by CIMA - Centro de Investigación Médica Aplicada

El Cancer Center Clínica Universidad de Navarra ha reunido en Madrid a expertos multidisciplinares para analizar y compartir los últimos progresos en inmunoterapia y terapias avanzadas frente a un c...

Read more

The Future of Pharma: 2025’s Key Trends To Know

by Rubió

The pharmaceutical industry in 2025 stands at a point of major change. AI and gene editing are making drug development faster. Cell therapies are becoming standard treatments. Digital tools are making...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream